Clinical Trial Update: A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for boron neutron capture therapy using B-10 L-BPA in recurrent meningioma; Phase 1/2, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• B-10 L-BPA (boron-10 labeled L-boronophenylalanine)

Snippet

Sponsor: Heron Neutron Medical Corp. | Conditions: Meningioma, Boron Neutron Capture Therapy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING